Introduction: The Routes to Diagnosis study has recorded data on new cancer diagnoses since 2006. The route to diagnosis of urological cancer influences outcomes and factors including gender, age and deprivation are implicated in affecting the way in which patients present. Materials and methods: Data were obtained from the National Cancer Intelligence Network Routes to Diagnosis study. Every new cancer case is assigned to one of eight routes of diagnosis, seven of which are applicable to urological cancers. Data from 2006 to 2013 are described in this report. Results: Two week wait is the most common route to diagnosis of bladder and testicular cancer compared to prostate, renal and penile malignancy in which routine general practitioner referral was the most common route. Two week wait referrals are associated with the best survival, and emergency presentations with the worst. Emergency presentation increases with advancing age but is also noted to be a significant route to diagnosis in patients less than 50 years. Bladder and renal cancer are more common in men but the route to diagnosis varies with gender. Increasing deprivation increases emergency presentation but has minimal effect on two week wait and routine general practitioner referrals. Conclusion: National data on the impact of route to diagnosis of urological malignancy have been described for the first time. The effect of age and gender on route to diagnosis and consequently cancer outcome has been noted. To enable earlier diagnosis attention must focus on extremes of age, patients with penile cancer and the most deprived patients.
Cancer outcomes in the UK compare unfavourably with those elsewhere in Europe. 1 The cause of this discrepancy can be substantially attributed to the very poor one year survival rates seen in the UK. This is thought to relate to late presentation of cancer and the current 'Be Clear on Cancer' campaign, 'Blood in Pee' is designed to address this by encouraging patients with visible haematuria to present to their general practitioner (GP). The two week wait (2WW) system was introduced in 2000 to promote expedited referral from primary care and subsequently earlier diagnosis. 2 In contrast, patients who present for the first time to emergency care can often have advanced disease.
The Routes to Diagnosis study has collected information on new cancer diagnoses from multiple national sources for 57 cancers from 2006 to 2013. The primary outcome of the study was to quantify numbers of patients diagnosed via the various routes, and to investigate the effect on survival. A detailed description of the study has previously been published. 3 The aim of this paper is to describe in detail the route to diagnosis (RTD) of urological cancer in England between 2006 and 2013 and to study patient characteristics that may influence the RTD and in turn survival.
Materials and methods
Data was obtained from the National Cancer Intelligence Network (NCIN) RTD. Every cancer case registered in England from 2006 until 2013 from the National Cancer Registration Service has been assigned to one of eight RTD. These are defined in Table 1 , except screen-detected which is not relevant to urological malignancies.
International Classifications of Diseases-10 codes were used as follows: penis C60, prostate C61, testis C62, kidney C64 and bladder C67. Age is categorised into 10-year age groups except for a single group for patients aged over 85 years. Deprivation data are categorised into five groups representing national quintiles of the income deprivation score from the Department for Communities and Local Government English Indices of Deprivation. 4
Results
There were 280,346 prostate cancer diagnoses. For men younger than 79 years, the most common RTD was GP referral. Overall, the most common RTD was GP referral, and prostate cancer was most commonly diagnosed in the least deprived patients.
A total of 70,043 diagnoses of bladder cancer were made between 2006 and 2013, 50,607 in men and 19,436 in women. The most common RTD overall was 2WW referral.
Between 2006 and 2013, there were 55,572 diagnoses of renal malignancy, 34,255 in men and 21,017 in women. More patients are diagnosed with renal cancer by emergency presentation than by 2WW. The most common RTD overall was a non-2WW GP referral.
There were 14,487 cases of testicular cancer. It is most frequently diagnosed in men less than 50 years. 2WW is the most common route overall.
Penile cancer is the rarest of the urological malignancies, only 3493 new diagnoses were made between 2006 and 2013. GP referral was the most common RTD across all age groups and levels of deprivation.
The percentage of patients referred by a 2WW pathway to secondary care was highest for testicular cancer and lowest for renal cancer. Prostate cancer, although the most common urological malignancy, evades the 2WW pathway in 67% of cases (see Figure 1 ).
For all urological malignancies, routine GP referral remains the most common RTD. Diagnoses made by 'other outpatient' referral occurred in 10-19% of cases and for 'inpatient elective' in 2-3% of cases. Diagnoses identified on 'death certificate only' range from 0% to 2% and are more common in older age groups. Unknown route accounts for 3-6% of patients and warrants further investigation.
Survival
Survival of patients varies by RTD. 2WW referrals are associated with the best survival and emergency presentation with the worst. Bladder cancer is associated with the poorest survival of the urological malignancies including in patients referred by 2WW, while testis cancer is associated with the highest survival rates. For each cancer type, the 2WW survival is higher than overall survival at 6, 12, 24 and 36 months (see Table 2 ).
Stage at diagnosis
To date there are incomplete data available on stage at presentation and this is critical to determining the direct impact on cancer-specific outcome of the RTD. The most complete data currently available are from 2012 to 2013 and are represented in Figure 2 for prostate, bladder and kidney. Even though, in a significant proportion the stage is unknown, it is clearly seen that 2WW presentation is more commonly associated with stage 1 disease and emergency presentation with stage 4 disease.
Effect of age
Across all five cancer types, diagnosis by emergency occurs with increasing frequency with advancing age. However, for bladder, kidney and penis cancer, diagnosis by emergency presentation is more common in patients less than 50 years than it is for patients aged 50-59 years (15% vs. 11%, 20% vs. 17% and 9% vs. 8%, respectively). As age increases, the percentage of patients referred by 2WW decreases. This is particularly apparent in patients aged over 85 years, in whom for all urological cancers, apart from penis, referral by 2WW was significantly lower than emergency presentation (see Table 3 ).
Effect of gender
Bladder and renal cancer are more common in men than in women. In bladder cancer, men are more likely to obtain diagnosis by 2WW or routine GP referral (35% and 29%, respectively) than by emergency presentation (16%). Women present more frequently by the emergency route (24%) and less commonly by 2WW or routine GP referral than men (32% and 27%, respectively). These gender differences are less pronounced for kidney cancer. Trends over time for bladder cancer are shown in Figure 3 . They demonstrate a clear increase in 2WW in both sexes and marginal falls in emergency presentation. In comparison, kidney cancer diagnoses in women were marginally more commonly referred by 2WW than men.
Effect of deprivation
Deprivation status has little effect on 2WW and routine referral but increasing deprivation increases the percentage of patients presenting as emergencies across all urological cancers. Prostate cancer diagnoses made by 2WW were 32% for both the most and least deprived patients, but for emergency presentation 7% were made in the least deprived group compared to 12% in the most deprived.
Discussion
For the first time, national data on the route by which patients reach a diagnosis of urological malignancy have been described in detail. This is significant as it is clear that specific factors affect the RTD, particularly age and gender, and that this influences survival. It is likely that there is a strong association with advanced stage and the emergency route although we do not have robust data on stage prior to 2012. Net survival accounts for the background mortality rates of the cohort, with respect to age, sex, deprivation, year and region of residence. This yields an estimate of the excess mortality due to the cancer in question, and hence acts as an estimate of cause-specific survival even when the underlying cause of death is not known. Referral patterns are inevitably influenced by cancerspecific signs and symptoms. For example, prostate cancer is commonly diagnosed incidentally in patients with lower urinary tract symptoms and hence by routine referral in 41% of cases. In contrast, those with bone pain due to metastases and obstructive uropathy tend to present by the emergency route and have a poorer prognosis. Similarly, symptoms in renal cancer are often a late phenomenon and are associated with advanced disease. Conversely, many small renal masses are asymptomatic, found incidentally and have a good prognosis, and are referred by elective routes in the vast majority.
Anxiety associated with a testicular lump may prompt patients to seek urgent GP opinion and subsequent referral onward to secondary care via the 2WW, resulting in 52% of diagnoses through this route. Penile cancer would be expected to have the same level of patient response; however, it is often ignored until advanced stages. Delay may be induced by referral to other specialties, but is most frequently due to failure to seek medical consultation. 5 Dedicated clinics such as haematuria clinics are widespread and allow the appropriate diagnostic tests, management plan and/or discharge decisions to be carried out during one visit. Patients who are referred outside the 2WW may not have the benefit of a coordinated assessment. Hence routine or urgent GP referrals can result in delay to diagnosis.
Emergency presentation is a common RTD of urological cancer. It is surprising, however, to find that a high proportion of patients under 50 years are diagnosed by the emergency route. This may represent attribution of symptoms to causes other than cancer and assumptions that cancer is less likely in this age group. However, 2.5% of bladder malignancies and 10.9% of renal malignancies were diagnosed in those under 50 years, and therefore there is a risk of missing younger patients with bladder or renal malignancy or delaying diagnosis if presentation occurs by alternative means.
Lyratzopoulos et al. suggest that cancer diagnosis by emergency presentation may be avoidable or unavoidable. 6 The avoidable cases are missed opportunities by primary care providers or by the patient previously to recognise the signs and symptoms of malignancy. Unavoidable cases may reflect the tumour type or development of acute symptoms with no identified prior symptoms. Measures should therefore be taken to address avoidable cases. 
